Migraine therapy that cut attacks hailed as ’huge deal’

A new approach to preventing migraines can cut the number and severity of attacks, two clinical trials show.

About 50% of people on one study halved the number of migraines they had each month, which researchers at King’s College Hospital called a ”huge deal”.

The treatment is the first specifically designed for preventing migraine and uses antibodies to alter the activity of chemicals in the brain.

Research has shown a chemical in the brain – calcitonin gene-related peptide or CGRP – is involved in both pain and sensitivity to sound and light in migraine.

Read the article in BBC.com/news/health >>>

 

Readers Comments


Comments are closed.

Migraine therapy that cut attacks hailed as ’huge deal’

A new approach to preventing migraines can cut the number and severity of attacks, two clinical trials show.

About 50% of people on one study halved the number of migraines they had each month, which researchers at King’s College Hospital called a ”huge deal”.

The treatment is the first specifically designed for preventing migraine and uses antibodies to alter the activity of chemicals in the brain.

Research has shown a chemical in the brain – calcitonin gene-related peptide or CGRP – is involved in both pain and sensitivity to sound and light in migraine.

Read the article in BBC.com/news/health >>>

 

backtotop